Interesting article. I note Opthea has the option to prepay its obligations at any time.
Megan Baldwin is quoted several times.
”This strategic transaction is expected to fund us through Phase 3 top-line data expected in mid-2024 and strengthens our strategic position to maximise the value of OPT-302”
”One of the really good points about the financing is that you can be in a stronger position to move it forward independently. It means we can make the right choices and only do a partnership deal that is
good - we’re not forced into a position of needing to do any one kind of deal, we’re independently funding through to top-line data readout.”
”That said, we’re remain open to partnership, because we recognise you can leverage the expertise and resources of a large pharmaceutical partner.”
- Forums
- ASX - By Stock
- News: OPT Opthea Ltd Says Offer Price For $90 Million Placement Is A$1.15 Per New Share
Interesting article. I note Opthea has the option to prepay its...
Featured News
Add OPT (ASX) to my watchlist
(20min delay)
|
|||||
Last
48.5¢ |
Change
-0.035(6.73%) |
Mkt cap ! $321.4M |
Open | High | Low | Value | Volume |
50.5¢ | 50.5¢ | 47.5¢ | $314.0K | 642.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 3270 | 48.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
49.5¢ | 9056 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 3270 | 0.480 |
1 | 60471 | 0.475 |
8 | 285214 | 0.470 |
4 | 67022 | 0.460 |
2 | 21980 | 0.455 |
Price($) | Vol. | No. |
---|---|---|
0.495 | 9056 | 2 |
0.500 | 213237 | 2 |
0.505 | 25000 | 1 |
0.510 | 10200 | 2 |
0.520 | 237551 | 5 |
Last trade - 16.10pm 06/06/2024 (20 minute delay) ? |
|
|||||
Last
48.5¢ |
  |
Change
-0.035 ( 6.73 %) |
|||
Open | High | Low | Volume | ||
49.0¢ | 50.0¢ | 47.5¢ | 78801 | ||
Last updated 15.59pm 06/06/2024 ? |
Featured News
OPT (ASX) Chart |